Literature DB >> 17459648

Insulin-like growth factor-I (IGF-I) inhibits neuronal apoptosis in the developing cerebral cortex in vivo.

Rebecca D Hodge1, A Joseph D'Ercole, John R O'Kusky.   

Abstract

Increased expression of insulin-like growth factor-I (IGF-I) in embryonic neural progenitors in vivo has been shown to accelerate neuron proliferation in the neocortex. In the present study, the in vivo actions of (IGF-I) on naturally occurring neuron death in the cerebral cortex were investigated during embryonic and early postnatal development in a line of transgenic (Tg) mice that overexpress IGF-I in the brain, directed by nestin genomic regulatory elements, beginning at least as early as embryonic day (E) 13. The areal density of apoptotic cells (N(A), cells/mm2) at E16 in the telencephalic wall of Tg and littermate control embryos was determined by immunostaining with an antibody specific for activated caspase-3. Stereological analyses were conducted to measure the numerical density (N(V), cells/mm3) and total number of immunoreactive apoptotic cells in the cerebral cortex of nestin/IGF-I Tg and control mice at postnatal days (P) 0 and 5. The volume of cerebral cortex and both the N(V) and total number of all cortical neurons also were determined in both cerebral hemispheres at P0, P5 and P270. Apoptotic cells were rare in the embryonic telencephalic wall at E16. However, the overall N(A) of apoptotic cells was found to be significantly less by 46% in Tg embryos. The volume of the cerebral cortex was significantly greater in Tg mice at P0 (30%), P5 (13%) and P270 (26%). The total number of cortical neurons in Tg mice was significantly increased at P0 (29%), P5 (29%) and P270 (31%), although the N(V) of cortical neurons did not differ significantly between Tg and control mice at any age. Transgenic mice at P0 and P5 exhibited significant decreases in the N(V) of apoptotic cells in the cerebral cortex (31% and 39%, respectively). The vast majority of these apoptotic cells (> 90%) were judged to be neurons by their morphological appearance. Increased expression of IGF-I inhibits naturally occurring (i.e. apoptotic) neuron death during early postnatal development of the cerebral cortex to a degree that sustains a persistent increase in total neuron number even in the adult animal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459648      PMCID: PMC2255566          DOI: 10.1016/j.ijdevneu.2007.03.004

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  51 in total

1.  Independent controls for neocortical neuron production and histogenetic cell death.

Authors:  C Verney; T Takahashi; P G Bhide; R S Nowakowski; V S Caviness
Journal:  Dev Neurosci       Date:  2000       Impact factor: 2.984

2.  Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation.

Authors:  B R Hu; C L Liu; Y Ouyang; K Blomgren; B K Siesjö
Journal:  J Cereb Blood Flow Metab       Date:  2000-09       Impact factor: 6.200

3.  Differences in survival-promoting effects and intracellular signaling properties of BDNF and IGF-1 in cultured cerebral cortical neurons.

Authors:  M Yamada; K Tanabe; K Wada; K Shimoke; Y Ishikawa; T Ikeuchi; S Koizumi; H Hatanaka
Journal:  J Neurochem       Date:  2001-09       Impact factor: 5.372

4.  Insulin-like growth factor-I overexpression attenuates cerebellar apoptosis by altering the expression of Bcl family proteins in a developmentally specific manner.

Authors:  D Chrysis; A S Calikoglu; P Ye; A J D'Ercole
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

5.  Delayed inner ear maturation and neuronal loss in postnatal Igf-1-deficient mice.

Authors:  G Camarero; C Avendano; C Fernandez-Moreno; A Villar; J Contreras; F de Pablo; J G Pichel; I Varela-Nieto
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

6.  Insulin-like growth factor-I is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2.

Authors:  Y Arsenijevic; S Weiss; B Schneider; P Aebischer
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

7.  Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development.

Authors:  J R O'Kusky; P Ye; A J D'Ercole
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

8.  Increased expression of insulin-like growth factor-I (IGF-I) during embryonic development produces neocortical overgrowth with differentially greater effects on specific cytoarchitectonic areas and cortical layers.

Authors:  Rebecca D Hodge; A Joseph D'Ercole; John R O'Kusky
Journal:  Brain Res Dev Brain Res       Date:  2004-12-30

9.  Insulin-like growth factor I, but not neurotrophin-3, sustains Akt activation and provides long-term protection of immature oligodendrocytes from glutamate-mediated apoptosis.

Authors:  Jennifer K Ness; Teresa L Wood
Journal:  Mol Cell Neurosci       Date:  2002-07       Impact factor: 4.314

10.  Defective neurogenesis in citron kinase knockout mice by altered cytokinesis and massive apoptosis.

Authors:  F Di Cunto; S Imarisio; E Hirsch; V Broccoli; A Bulfone; A Migheli; C Atzori; E Turco; R Triolo; G P Dotto; L Silengo; F Altruda
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

View more
  21 in total

Review 1.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

2.  beta-catenin mediates insulin-like growth factor-I actions to promote cyclin D1 mRNA expression, cell proliferation and survival in oligodendroglial cultures.

Authors:  Ping Ye; Qichen Hu; Hedi Liu; Yun Yan; A Joseph D'ercole
Journal:  Glia       Date:  2010-07       Impact factor: 7.452

Review 3.  The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease.

Authors:  Bhumsoo Kim; Sarah E Elzinga; Rosemary E Henn; Lisa M McGinley; Eva L Feldman
Journal:  Neurobiol Dis       Date:  2019-07-23       Impact factor: 5.996

Review 4.  The effects of testosterone and insulin-like growth factor 1 on motor system form and function.

Authors:  Kentaro Oki; Timothy D Law; Anne B Loucks; Brian C Clark
Journal:  Exp Gerontol       Date:  2015-02-11       Impact factor: 4.032

5.  Insulin-Like Growth Factor-1 Receptor Is Differentially Distributed in Developing Cerebellar Cortex of Rats Born to Diabetic Mothers.

Authors:  Javad Hami; Saeed Vafaei-Nezhad; Delaram Haghir; Hossein Haghir
Journal:  J Mol Neurosci       Date:  2015-10-13       Impact factor: 3.444

6.  Prostaglandin E2-induced synaptic plasticity in neocortical networks of organotypic slice cultures.

Authors:  Henner Koch; Sung-Eun Huh; Frank P Elsen; Michael S Carroll; Rebecca D Hodge; Francesco Bedogni; Michael S Turner; Robert F Hevner; Jan-Marino Ramirez
Journal:  J Neurosci       Date:  2010-09-01       Impact factor: 6.167

7.  Efficient Expression of Igf-1 from Lentiviral Vectors Protects In Vitro but Does Not Mediate Behavioral Recovery of a Parkinsonian Lesion in Rats.

Authors:  Ngoc B Lu-Nguyen; Martin Broadstock; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther       Date:  2015-10-01       Impact factor: 5.695

8.  Insulin growth factor signaling mediates neuron-like differentiation of adipose-tissue-derived stem cells.

Authors:  Hongxiu Ning; Guiting Lin; Thomas Fandel; Lia Banie; Tom F Lue; Ching-Shwun Lin
Journal:  Differentiation       Date:  2007-11-15       Impact factor: 3.880

Review 9.  Expanding the mind: insulin-like growth factor I and brain development.

Authors:  A Joseph D'Ercole; Ping Ye
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

10.  Mosaic Analysis with Double Markers reveals IGF1R function in granule cell progenitors during cerebellar development.

Authors:  Tiffany T Terry; Tao Cheng; Moe Mahjoub; Hui Zong
Journal:  Dev Biol       Date:  2020-07-19       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.